ARCHIVES

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

New Chemoprevention Program Will Get “Whatever Money It Need;” Clinical Trials In New Division

July 25, 1980

Senate Committee Proposes $301 Million Increase For NIH

September 22, 1995

Planned Parenthood May Be Doing Harm By Selling Breast Cancer Screening to Women Under 40

February 10, 2012

Fred Conrad, MDA VP, Shot To Death In Hospital Office

January 7, 1983

In Brief: NCI Tells Cooperative Groups To Submit applications For Extra Multimodality Funds

November 28, 1975

Panel To Hear Centers’ Problems Again; Alabama, Mayo Impress Site visitors

March 18, 1977